(AZAL) AllianzIM U.S. Large Cap - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US00888H3075

ETF, Buffer, Call Options, Put Options, S&P 500

Description: AZAL AllianzIM U.S. Large Cap

The AllianzIM U.S. Large Cap Buffer10 Jul ETF (AZAL) is designed to provide investors with exposure to the S&P 500 Price Index while implementing a buffer strategy to mitigate potential losses. By utilizing FLEX Options that reference the S&P 500 Price Index, the fund aims to limit downside risk while still allowing for potential gains.

The S&P 500 Price Index is a widely followed benchmark that tracks the performance of the US stock markets largest and most liquid companies. As a market-weighted index, it provides a representation of the overall US equity market, making it a suitable reference point for AZALs investment strategy.

AZALs non-diversified nature means that it may be more susceptible to market fluctuations, as its performance is closely tied to the S&P 500 Price Index. However, the funds defined outcome strategy is designed to provide a level of protection against losses, making it an attractive option for investors seeking to balance risk and potential returns.

Analyzing the technical data, we can see that AZALs price has been trending upwards, with its 20-day and 50-day simple moving averages (SMA) indicating a bullish signal. The stock is currently trading above its 20-day and 50-day SMAs, and its average true range (ATR) suggests moderate volatility. With a 52-week high and low of $40.73 and $35.20, respectively, the current price of $40.12 is near the upper end of its recent trading range.

Given the current technical and fundamental data, our forecast suggests that AZAL may continue to trend upwards, potentially reaching $41.50 in the near term. This is based on the funds bullish technical indicators, as well as the overall positive trend in the S&P 500 Price Index. However, investors should be cautious of potential market volatility and the funds non-diversified nature, which may impact its performance. With an AUM of $72.09M, AZAL has sufficient assets to maintain its investment strategy, but investors should continue to monitor the funds performance and adjust their expectations accordingly.

Additional Sources for AZAL ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

AZAL ETF Overview

Market Cap in USD 80m
Category Defined Outcome
TER 0.74%
IPO / Inception 2020-06-30

AZAL ETF Ratings

Growth Rating 72.7
Fundamental -
Dividend Rating 1.0
Rel. Strength -1.32
Analysts -
Fair Price Momentum 40.89 USD
Fair Price DCF -

AZAL Dividends

Currently no dividends paid

AZAL Growth Ratios

Growth Correlation 3m 97.2%
Growth Correlation 12m 52.9%
Growth Correlation 5y 92.6%
CAGR 5y 11.21%
CAGR/Max DD 5y 0.83
Sharpe Ratio 12m 1.75
Alpha 1.80
Beta 0.673
Volatility 7.35%
Current Volume 6.7k
Average Volume 20d 13.7k
Stop Loss 40.7 (-3%)
What is the price of AZAL shares?
As of July 16, 2025, the stock is trading at USD 41.98 with a total of 6,700 shares traded.
Over the past week, the price has changed by +0.42%, over one month by +3.66%, over three months by +12.84% and over the past year by +11.17%.
Is AllianzIM U.S. Large Cap a good stock to buy?
Yes. Based on ValueRay's Analyses, AllianzIM U.S. Large Cap (NYSE ARCA:AZAL) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 72.67 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AZAL is around 40.89 USD . This means that AZAL is currently overvalued and has a potential downside of -2.6%.
Is AZAL a buy, sell or hold?
AllianzIM U.S. Large Cap has no consensus analysts rating.
What are the forecasts for AZAL share price target?
According to our own proprietary Forecast Model, AZAL AllianzIM U.S. Large Cap will be worth about 45.9 in July 2026. The stock is currently trading at 41.98. This means that the stock has a potential upside of +9.43%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 45.9 9.4%